Plant · Scientific monograph
Polygala tenuifolia
Yuan Zhi / Chinese Polygala Root
For educational and scientific research only. Not medical advice. Independently verify claims against the cited primary sources. Consult a qualified healthcare professional before using any plant or fungal preparation.
Research areas: Cognitive Function Research, Memory Research, Neurological & Cognitive Research, Traditional Chinese Medicine Research
Research overview
Historical use
Polygala tenuifolia root is known in Traditional Chinese Medicine as Yuan Zhi, traditionally used in formulas for forgetfulness, restlessness, sleep disturbance, and spirit-calming indications. These uses are traditional and formula-based, and they do not establish isolated-species clinical efficacy.
Modern research context
Human cognitive research is concentrated on BT-11, a Polygala tenuifolia root extract, with small randomized studies in healthy adults and elderly adults reporting improvements in verbal learning, recognition, and memory-related test batteries [1][2]. A 2024 meta-analysis evaluated the Polygala tenuifolia-Acorus tatarinowii herb pair as an adjunct in Alzheimer's disease, but this evidence is combination-based and rated low or very low quality, so it cannot be attributed to Polygala alone [3]. Mechanistic reviews emphasize saponins and related constituents in dementia models, but much of that literature is preclinical [4]. A separate clinical study in adolescents provides some product-specific tolerability information for BT-11 rather than adult long-term efficacy [5].
Adverse effects
Saponin-rich Polygala root preparations may cause gastrointestinal irritation, nausea, abdominal discomfort, or throat irritation. Human BT-11 studies were small and do not establish long-term adult tolerability. Combination TCM studies cannot isolate Polygala-specific adverse effects.
Contraindications
Avoid in known allergy to Polygala species. Use caution in active gastritis, peptic ulcer disease, severe reflux, or high GI sensitivity because saponins can irritate mucosa. Use caution with CNS-active medications and cholinergic agents because cognitive mechanisms under investigation include neurotrophic and cholinergic pathways, but clinically graded interaction data are lacking.
Clinical and phytochemical data
Used part
Dried root; BT-11 root extract in human memory studies. Traditional formulas may combine Polygala with Acorus and other herbs.
Primary active compounds
Tenuifolin
Tenuigenin
Polygalasaponins
Onjisaponin B
Senegenin
3,6'-disinapoyl sucrose
Xanthone glycosides
Mechanism of action
Polygala root constituents are investigated for effects on BDNF, CREB, synaptic plasticity, and cholinergic signaling in memory models [4]. Saponins such as tenuifolin and onjisaponins are studied for modulation of acetylcholinesterase, neuroinflammation, and amyloid-related pathways, primarily in preclinical systems [4]. Human BT-11 trials provide cognitive test signals but do not establish a complete mechanism in humans [1][2].
Pharmacokinetics
Absorption
No comprehensive human pharmacokinetic dataset exists for Polygala tenuifolia root extract. Saponins are generally poorly absorbed intact and may be transformed by intestinal microbiota; sucrose esters and xanthones may have different absorption profiles [4].
Distribution
Human distribution data are insufficient. Preclinical studies suggest some Polygala-derived metabolites may affect central nervous system pathways, but direct human brain distribution for BT-11 or root extract is not established [4].
Metabolism
Saponins may undergo deglycosylation by gut microbiota followed by hepatic conjugation of absorbed aglycones. Human CYP450 interaction data for Polygala tenuifolia are not established [4].
Excretion
Elimination routes and half-lives for BT-11 and Polygala root saponins are not defined in humans. Metabolites are expected to be eliminated through urinary and biliary pathways after conjugation [4].
Safety and interactions
Drug interactions
No clinically graded herb-drug interaction studies were identified. Precautionary concerns include additive CNS effects with sedatives or stimulants and theoretical interaction with cholinergic or anticholinergic drugs, based on cognitive and cholinergic mechanisms under investigation [1][4].
Toxicity
Human clinical tolerability data are limited to small BT-11 studies and a product-specific adolescent tolerability study [1][2][5]. Saponin-rich preparations can irritate the gastrointestinal tract; chronic high-dose toxicity in adults is not adequately characterized by the cited literature.
Special precautions
Pregnancy
Insufficient human data for Polygala tenuifolia during pregnancy. Avoid medicinal-dose root preparations as a precaution.
Lactation
Insufficient data on transfer into human milk. Avoid medicinal-dose preparations during lactation as a precaution.
Hepatic impairment
No formal hepatic-impairment studies. Use caution because absorbed constituents likely undergo hepatic metabolism.
Renal impairment
No formal renal-impairment studies and no dose-adjustment guidance. Use caution in severe renal impairment.
Sources and references
- [1] - Lee JY et al. Effects of BT-11 on memory in healthy humans. Neurosci Lett, 2009. PMID: 19429065
- [2] - Shin KY et al. BT-11 is effective for enhancing cognitive functions in the elderly humans. Neurosci Lett, 2009. PMID: 19699261
- [3] - Zhang Y et al. Polygala tenuifolia and Acorus tatarinowii in the treatment of Alzheimer's disease: a systematic review and meta-analysis. Front Pharmacol, 2023. PMID: 38283842
- [4] - Li S et al. Saponin components in Polygala tenuifolia as potential candidate drugs for treating dementia. Front Pharmacol, 2024. PMID: 39050746
- [5] - Park CH et al. Study on the safety of Polygala tenuifolia Willdenow root extract powder (BT-11) in young person aged from 9 to 19 years old. J Ethnopharmacol, 2019. PMID: 30576772